Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75


Male Breast Cancer.

Yalaza M, İnan A, Bozer M.

J Breast Health (2013). 2016 Jan 1;12(1):1-8. doi: 10.5152/tjbh.2015.2711. eCollection 2016 Jan 1. Review.


Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.

Kamps R, Brandão RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, Romano A.

Int J Mol Sci. 2017 Jan 31;18(2). pii: E308. doi: 10.3390/ijms18020308. Review.


Genomic Disparities in Breast Cancer Among Latinas.

Lynce F, Graves KD, Jandorf L, Ricker C, Castro E, Moreno L, Augusto B, Fejerman L, Vadaparampil ST.

Cancer Control. 2016 Oct;23(4):359-372.


Li-Fraumeni Syndrome.

Correa H.

J Pediatr Genet. 2016 Jun;5(2):84-8. doi: 10.1055/s-0036-1579759. Epub 2016 Apr 13. Review.


Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.

Mai PL, Best AF, Peters JA, DeCastro RM, Khincha PP, Loud JT, Bremer RC, Rosenberg PS, Savage SA.

Cancer. 2016 Dec 1;122(23):3673-3681. doi: 10.1002/cncr.30248. Epub 2016 Aug 6.


Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome.

Park KJ, Choi HJ, Suh SP, Ki CS, Kim JW.

Ann Lab Med. 2016 Sep;36(5):463-8. doi: 10.3343/alm.2016.36.5.463.


Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation.

Andrade KC, Santiago KM, Fortes FP, Mambelli LI, Nóbrega AF, Achatz MI.

Genet Mol Biol. 2016 May 24;39(2):199-202. doi: 10.1590/1678-4685-GMB-2014-0343.


Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO).

Choi MC, Lim MC, Suh DH, Song YJ, Kim TJ, Chang SJ, Kim JW; Korean Society of Gynecologic Oncology..

J Gynecol Oncol. 2016 Jul;27(4):e36. doi: 10.3802/jgo.2016.27.e36. Epub 2016 Mar 30. No abstract available.


Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland.

Wojcik P, Jasiowka M, Strycharz E, Sobol M, Hodorowicz-Zaniewska D, Skotnicki P, Byrski T, Blecharz P, Marczyk E, Cedrych I, Jakubowicz J, Lubiński J, Sopik V, Narod S, Pierzchalski P.

Hered Cancer Clin Pract. 2016 Feb 3;14:5. doi: 10.1186/s13053-016-0046-5. eCollection 2016 Feb 3.


Pubertal outcome in a female with virilizing adrenocortical carcinoma.

Breidbart E, Cameo T, Garvin JH, Hibshoosh H, Oberfield SE.

J Pediatr Endocrinol Metab. 2016 Apr;29(4):503-9. doi: 10.1515/jpem-2015-0123.


Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.

Inoue K, Fry EA.

Int J Cancer. 2016 Jul 1;139(1):33-41. doi: 10.1002/ijc.30003. Epub 2016 Feb 8. Review.


Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma.

Bussey KJ, Bapat A, Linnehan C, Wandoloski M, Dastrup E, Rogers E, Gonzales P, Demeure MJ.

Clin Transl Med. 2016 Mar;5(1):1. doi: 10.1186/s40169-015-0080-3. Epub 2016 Jan 11.


Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.

Churpek JE, Marquez R, Neistadt B, Claussen K, Lee MK, Churpek MM, Huo D, Weiner H, Bannerjee M, Godley LA, Le Beau MM, Pritchard CC, Walsh T, King MC, Olopade OI, Larson RA.

Cancer. 2016 Jan 15;122(2):304-11. doi: 10.1002/cncr.29615. Epub 2015 Dec 7.


Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.

Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN.

Front Oncol. 2015 Sep 29;5:208. doi: 10.3389/fonc.2015.00208. eCollection 2015 Sep 29. Erratum in: Front Oncol. 2015;5:271.


Efficacy of the porcine species in biomedical research.

Gutierrez K, Dicks N, Glanzner WG, Agellon LB, Bordignon V.

Front Genet. 2015 Sep 16;6:293. doi: 10.3389/fgene.2015.00293. eCollection 2015 Sep 16.


Breast cancer following spinal irradiation for a childhood cancer: A report from the Childhood Cancer Survivor Study.

Moskowitz CS, Malhotra J, Chou JF, Wolden SL, Weathers RE, Stovall M, Armstrong GT, Leisenring WM, Neglia JP, Robison LL, Oeffinger KC.

Radiother Oncol. 2015 Nov;117(2):213-6. doi: 10.1016/j.radonc.2015.09.016. Epub 2015 Sep 18.


Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.

Yurgelun MB, Masciari S, Joshi VA, Mercado RC, Lindor NM, Gallinger S, Hopper JL, Jenkins MA, Buchanan DD, Newcomb PA, Potter JD, Haile RW, Kucherlapati R, Syngal S; Colon Cancer Family Registry..

JAMA Oncol. 2015 May;1(2):214-21.


Hereditary ovarian cancer: not only BRCA 1 and 2 genes.

Toss A, Tomasello C, Razzaboni E, Contu G, Grandi G, Cagnacci A, Schilder RJ, Cortesi L.

Biomed Res Int. 2015;2015:341723. doi: 10.1155/2015/341723. Epub 2015 May 17. Review.


The benefit and burden of cancer screening in Li-Fraumeni syndrome: a case report.

Jhaveri AP, Bale A, Lovick N, Zuckerman K, Deshpande H, Rath K, Schwartz P, Hofstatter EW.

Yale J Biol Med. 2015 Jun 1;88(2):181-5. eCollection 2015 Jun 1.


Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.

Yang X, Wu J, Lu J, Liu G, Di G, Chen C, Hou Y, Sun M, Yang W, Xu X, Zhao Y, Hu X, Li D, Cao Z, Zhou X, Huang X, Liu Z, Chen H, Gu Y, Chi Y, Yan X, Han Q, Shen Z, Shao Z, Hu Z.

PLoS One. 2015 Apr 30;10(4):e0125571. doi: 10.1371/journal.pone.0125571. eCollection 2015 Apr 30.

Supplemental Content

Support Center